Aveanna Healthcare reports Q3 revenue up 11.8% and raises 2026 revenue and EBITDA guidance.

Aveanna Healthcare Holdings announced its third quarter 2026 financial results with revenue of $695.5 million, up 11.8% year-over-year, and net income of $45.5 million, significantly higher than the previous year's $14.1 million. Adjusted EBITDA rose 25% to $100.1 million, reflecting strong organic growth across all business segments. The company raised its full-year 2026 revenue guidance to over $2.695 billion and adjusted EBITDA guidance to over $374 million, citing confidence in continued growth and operational strength. Aveanna's focus on home healthcare for medically complex patients and strategic initiatives contributed to the positive results and outlook.

Aveanna Healthcare Holdings (AVAH) trades at USD 12.20 on Pluang as of Nov 12, 2026 19:13 WIB, down 6.80% in one day. Despite the recent dip in share price, the company’s market cap stands at $2.86 billion, reflecting significant investor interest following its strong third quarter results and raised 2026 guidance. Volume on the platform is active with over 1.65 million shares traded, indicating continued market attention to this healthcare stock.